& Mailloux, R
When administered as a once-weekly subcutaneous injection, Ozempic helps to: Stimulate insulin secretion from pancreatic beta cells in a glucose-dependent manner Suppress glucagon release , reducing hepatic glucose production Slow gastric emptying , which helps control post-meal blood sugar spikes Promote satiety , leading to reduced calorie intake and potential weight loss Ozempic treatment typically begins with a 0.25 mg weekly dose for 4 weeks, which is then increased to 0.5 mg weekly, with further titration to 1 mg if needed for glycaemic control
However, the needles are extremely thin, and the process is straightforward
A long-term study reveals how tirzepatide not only cuts weight but also slashes diabetes risk in people with prediabetes, highlighting a major advance in obesity and diabetes care
A., Sachidanandam, R., Girard, A., Fejes-Toth, K